Disease
7 developments in the corpus
Following this puts new work involving it at the top of your briefing, with a note saying why it is there. Links are taken from the source record, never inferred.
Latest
Everything in the corpus, newest first.
SEP 9, 2026 · PHASE 1 TRIAL
ClinicalTrials.gov
This is a Phase 1, first-in-human study registration with no results posted; it describes planned enrollment and safety endpoints only, representing early-stage drug development.
AUG 20, 2026 · PHASE 3 TRIAL
ClinicalTrials.gov
This is a Phase 3 trial registration with no results posted; the planned design is rigorous but outcomes remain unknown and unverified.
AUG 19, 2026 · INTERVENTIONAL STUDY
ClinicalTrials.gov
This is an active, uncontrolled pilot feasibility study evaluating acceptability and provider feasibility of a decision support tool in advanced breast cancer; no results are posted in this registry record.
AUG 19, 2026 · PHASE 1 TRIAL
ClinicalTrials.gov
This is a Phase 1 dose-escalation and dose-expansion trial registration with no results posted; it is a first-in-human safety and tolerability study designed to establish dosing, not efficacy.
AUG 13, 2026 · PHASE 3 TRIAL
ClinicalTrials.gov
This is a registry record for an ongoing Phase 3 trial with no results yet reported; the study design is sound but evidence cannot be evaluated until data are available.
AUG 7, 2026 · PHASE 2 TRIAL
ClinicalTrials.gov
This is a recruiting Phase 2 study with no results posted; it describes a planned safety and tolerability evaluation in a small population with an estimated 24 participants.
AUG 4, 2026 · PHASE 1 TRIAL
ClinicalTrials.gov
Clinical trial registry record for terminated Phase 1 study with no results reported; preliminary status reflects early-stage investigation without outcome data.